Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone
NCT ID: NCT00911105
Last Updated: 2018-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
101 participants
OBSERVATIONAL
2009-05-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination of Lenalidomide and Dexamethasone in Treatment of Multiple Myeloma
NCT01090089
Non-interventional Study of Lenalidomide / Dexamethasone as First Line Therapy in Patients With Multiple Myeloma
NCT02537808
Lenalidomide/Low-dose Dexamethasone in Combination With Continuous Oral Cyclophosphamide Compared to Lenalidomide/Low-dose Dexamethasone Combined With Single Cyclophosphamide Doses IV in Patients With Relapsed/Refractory Multiple Myeloma
NCT01019174
Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
NCT01010243
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
NCT01861340
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with multiple myeloma
Patients with multiple myeloma receiving second line therapy or higher.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Signed, written informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
iOMEDICO AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Onkologische Schwerpunktpraxis
Bad Homburg, , Germany
Onkologische Schwerpunktpraxis
Berlin, , Germany
Onkologisches Versorgungszentrum Friedrichshain
Berlin, , Germany
Onkologische Praxis
Berlin, , Germany
Onkologische Gemeinschaftspraxis
Frankfurt am Main, , Germany
Praxis für Innere Medizin
Germering, , Germany
MedResearch - Medizinisches Studien- und Dokumentationszentrum Leipziger Land
Groitzsch, , Germany
Internistische Gemeinschaftspraxis
Güstrow, , Germany
Praxis für Innere Medizin, Haematologie und Internistische Onkologie
Hamburg, , Germany
Tumorpraxis Heidenheim
Heidenheim, , Germany
Onkol. Gem.praxis Dr. M. Neise & Dr. A. Lollert
Krefeld, , Germany
Onkologisches Zentrum Lebach
Lebach, , Germany
Onkologische Gemeinschaftspraxis
Lehrte, , Germany
Gemeinschaftspraxis Dr. Aldaoud - Dr. Schwarzer
Leipzig, , Germany
Praxis für Haematologie und Onkologie
Mühlheim, , Germany
Praxis fuer Innere Medizin
Neumarkt I. D. O., , Germany
Praxis fuer Onkologie und Haematologie
Neuss, , Germany
Haematologisch-Onkologische Gemeinschaftspraxis
Nordhorn, , Germany
Onkologische Praxis Oldenburg
Oldenburg, , Germany
Onkologische Gemeinschaftspraxis
Würselen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IOM-0810
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.